Chemo Pharma Laboratories Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported total income from operations of INR 552,000 compared with INR 326,000 for the same period a year ago. Loss from operation before other income, finance cost and exceptional items was INR 72,000 compared with profit of INR 75,000 for the same period a year ago. Loss from ordinary activities before tax was INR 72,000 compared with profit of INR 75,000 for the same period a year ago. Net loss was INR 72,000 or INR 0.05 per basic and diluted share before and after extraordinary items compared with profit of INR 75,000 or INR 0.05 per basic and diluted share before and after extraordinary items for the same period a year ago. For the nine months, the company reported total income from operations of INR 2,967,000 compared with INR 2,374,000 for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 1,382,000 compared with INR 1,361,000 for the same period a year ago. Profit from ordinary activities before tax was INR 1,382,000 compared with INR 1,361,000 for the same period a year ago. Net profit was INR 1,382,000 or INR 0.92 per basic and diluted share before and after extraordinary items compared with INR 1,361,000 or INR 0.91 per basic and diluted share before and after extraordinary items for the same period a year ago.